↓ Skip to main content

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
31 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
183 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd009019.pub2
Pubmed ID
Authors

Kayleigh M Kew, Charlotta Karner, Stephanie M Mindus, Giovanni Ferrara

Abstract

Asthma is characterised by chronic inflammation of the airways and recurrent exacerbations with wheezing, chest tightness and cough. Treatment with inhaled steroids and bronchodilators often results in good control of symptoms, prevention of further morbidity and mortality and improved quality of life. Several steroids and beta2-agonists (long- and short-acting) as well as combinations of these treatments are available in a single inhaler to be used once or twice a day, with a separate inhaler for relief of symptoms when needed (for patients in Step three or higher, according to Global Initiative for Asthma (GINA) guidelines). Budesonide/formoterol is also licenced for use as maintenance and reliever therapy from a single inhaler (SiT; sometimes referred to as SMART therapy). SiT can be prescribed at a lower dose than other combination therapy because of the additional steroid doses being received as reliever therapy. It has been suggested that using SiT improves compliance and hence reduces symptoms and exacerbations, but it is unclear whether it increases side effects associated with the use of inhaled steroids.

Twitter Demographics

The data shown below were collected from the profiles of 31 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Tunisia 1 <1%
Brazil 1 <1%
Egypt 1 <1%
Mexico 1 <1%
Germany 1 <1%
Unknown 176 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 32 17%
Researcher 23 13%
Student > Bachelor 23 13%
Student > Ph. D. Student 21 11%
Other 15 8%
Other 45 25%
Unknown 24 13%
Readers by discipline Count As %
Medicine and Dentistry 100 55%
Nursing and Health Professions 11 6%
Psychology 11 6%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Agricultural and Biological Sciences 8 4%
Other 17 9%
Unknown 27 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2017.
All research outputs
#666,594
of 14,354,323 outputs
Outputs from Cochrane database of systematic reviews
#2,008
of 10,946 outputs
Outputs of similar age
#10,350
of 224,130 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 141 outputs
Altmetric has tracked 14,354,323 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,946 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,130 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.